Krajina: Grécko
Jazyk: angličtina
Zdroj: HMA (Heads of Medicines Agencies)
marbofloxacin magnesium salt 100 mg
Sogeval
QJ01MA93
Chewable tablet
marbofloxacin
Dogs Non Food
2013-02-20
AN: 00347/2013 Revised: August 2013 Page 1 of 6 SUMMARY OF THE PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Efex 100 mg chewable tablets for dogs Efex vet 100 mg chewable tablets for dogs (FI, SE) Axor vet 100 mg chewable tablets for dogs (NO) Axor 100 mg chewable tablets for dogs (DK) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One tablet contains: ACTIVE SUBSTANCE: Marbofloxacin .................................................. 100.0 mg EXCIPIENT(S): For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Chewable tablet Clover-shaped scored beige tablet. The tablet can be divided into four equal parts 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE,SPECIFYING THE TARGET SPECIES In dogs Marbofloxacin is indicated in the treatment of: - skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis, furunculosis, cellulitis) caused by susceptible strains of _organisms._ - urinary tract infections (UTI) caused by susceptible strains of organisms associated or not with prostatitis or epididymitis. - respiratory tract infections caused by susceptible strains of _organisms_. 4.3 CONTRAINDICATIONS AN: 00347/2013 Revised: August 2013 Page 2 of 6 Do not use in dogs aged less than 12 months, or less than 18 months for giant breeds of dogs with a longer growth period. Do not use in cases of hypersensitivity to (fluoro)quinolones. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES A low urinary pH could have an inhibitory effect on the activity of marbofloxacin. 4.5 SPECIAL PRECAUTIONS FOR USE (I) Prečítajte si celý dokument